Status:
UNKNOWN
Efficacy Study of Comprehensive Rehabilitation Program in Postoperative NSCLC Patients
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Collaborating Sponsors:
Shanghai Chest Hospital
Shanghai Pulmonary Hospital, Shanghai, China
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The investigators performed a multi-centered, randomized, placebo-controlled, prospective clinical trial on the effect of comprehensive rehabilitation program to improve quality of life(QOL) and long-...
Detailed Description
Non-Small-Cell Lung Cancer（NSCLC）is one of the malignancies with high incidence and mortality. In recent years, surgery become the preferred treatment for early stage of NSCLC. Patients with stage IA-...
Eligibility Criteria
Inclusion
- Pathologically or cytologically confirmed stage Ia-IIIa non small cell lung cancer;
- Between the ages of 18 to 75 years old;
- The score of ECOG ≥2 points
- Without major organ dysfunction: hemoglobin ≥10 g/dL, absolute neutrophil count (ANC) ≥1.5\*10\^9/L, platelets ≥100 \*10\^9/L; normal hepatic and renal function
Exclusion
- Indefinite pathological diagnosis;
- Expected survival time \< 6 months
- Combined with heart, liver, kidney and hematopoietic system and other serious diseases
- The patient was treated with antibiotics or infected one week before the test;
- Pregnant or child breast feeding women;
- Mental or cognitive disorders;
Key Trial Info
Start Date :
October 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2019
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT03244605
Start Date
October 1 2016
End Date
December 30 2019
Last Update
June 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
YueYang Hosptial of Intergrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China, 200437